Gut problems like irritable bowel syndrome are often worse in women. A mouse study reveals a pain pathway involving estrogen, ...

Women are dramatically more likely than men to suffer from irritable bowel syndrome (IBS), a chronic condition causing ...

Previous research has shown that many more women than men have the chronic condition, known as IBS, that causes abdominal ...

Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...

Athira Pharma has joined an attempt to rescue an asset abandoned by Pfizer. The biotech has secured near-global rights to a phase 3 breast cancer prospect in a deal with Sermonix Pharmaceuticals.

In this video, Eleonora Teplinsky, MD, discusses the lidERA trial, presented at San Antonio Breast Cancer Symposium, and what questions and research remain for use of giredestrant in breast cancer.The ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

In a separate release, on December 9, Eli Lilly and Company (NYSE:LLY) announced its plans to invest over $6 billion in new manufacturing facility in Huntsville, Alabama. The next-generation synthetic ...

Hormone therapies have played a major role in improving survival for patients with ER+ breast cancer [1]. By blocking or reducing estrogen’s impact, these treatments slow the cancer’s growth and help ...

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...